Medical options for early pregnancy termination

Research output: Contribution to journalReview articlepeer-review

10 Scopus citations

Abstract

Newly developed protocols using methotrexate and misoprostol are more than 90 percent effective in terminating pregnancies of less than seven weeks of gestation. Major side effects include cramping and bleeding. In a significant minority of women, the abortion is completed only after a prolonged wait. Nonetheless, abortions completed with methotrexate and misoprostol have been well tolerated and acceptable to patients. Mifepristone (formerly called RU 486) will soon be available in the United States. When used with misoprostol, mifepristone successfully terminates 94 to 99 percent of early pregnancies.

Original languageEnglish (US)
Pages (from-to)533-5378
Number of pages4846
JournalAmerican family physician
Volume56
Issue number2
StatePublished - Aug 1 1997

ASJC Scopus subject areas

  • Family Practice

Fingerprint Dive into the research topics of 'Medical options for early pregnancy termination'. Together they form a unique fingerprint.

Cite this